CDKN2B and colorectal carcinoma: In CRC, an aberrant expression of long noncoding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) inhibits cell proliferation, migration, and apoptosis through the activation of MAPKs signaling.